Navigation Links
HeartWare International Reports Third Quarter Revenues of $7.5 Million
Date:11/4/2009

ollowing completion of the call.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIb and Class IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD(TM) pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has received CE Marking for the HeartWare® Ventricular Assist System in the European Union. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication. For additional information, please visit the company's website at www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

    For further information:
    U.S. Investor Relations
    Matt Clawson
    Allen & Caron, Inc.
    Email. matt@allencaron.com
    Tel. +1 949 474 4300

Forward-Looking Statements

This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the progress of clinical trials. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue re
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
6. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
9. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
10. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
11. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held ... Philip Ranker as Vice President and Chief Financial Officer. ... Suneva Medical,s general and administrative functions including finance, accounting, ... also serve on the Company,s senior management team. ...
(Date:12/4/2009)... announced the three grand prize winners of Bayer,s "Express Your ... selected the winning video entries submitted by children with diabetes ... meeting today with Nick. ,, The winners, who ... from Danbury, CT, who dreams of becoming a major league ...
(Date:12/4/2009)... disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), ... comorbidities reported to occur more often in people ... versus those without an epilepsy diagnosis, according to ... U.S. ,, Findings from " CNS-Related Comorbidities in ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Fall Chores Spark Safety Advice From Orthopaedic Surgeons 57995 1Fall Chores Spark Safety Advice From Orthopaedic Surgeons 57995 2Fall Chores Spark Safety Advice From Orthopaedic Surgeons 57995 3Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 57991 1Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 57991 2US Farms Inc Announces Agreement With Rage Marketing Inc to Increase Brand Awareness and E Commerce Product Sales 57987 1US Farms Inc Announces Agreement With Rage Marketing Inc to Increase Brand Awareness and E Commerce Product Sales 57987 2US Farms Inc Announces Agreement With Rage Marketing Inc to Increase Brand Awareness and E Commerce Product Sales 57987 3
... Kiwifruit is Top Performer in the Body, SEATTLE, ... when,it comes to their antioxidant powers in the body: ... antioxidant-rich fruits and,berries in a recent small-scale study published ... Antioxidants include vitamins and phytochemicals called flavonoids that,may have ...
... 3 All newborn infants,should be screened for ... to a new recommendation from the U.S. Preventive ... of evidence appear,in the July 7 issue of ... birth, during infancy or in early,childhood can have ...
Other Medicine Technology:Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3
(Date:12/7/2009)... Dec. 7 Today the Centers for Disease ... Influenza Vaccination Week. While the week was designed to ... to light the importance of taking additional steps to ... cold and flu season of December, January and beyond. ... information circulating around the topic of both seasonal and ...
(Date:12/7/2009)... may suffer from more emotional and behavioral difficulties when ... girls struggling the most when a parent is deployed ... Researchers found that having a parent deployed for a ... who has struggled with emotional problems were important factors ... to the study published online by the journal ...
(Date:12/7/2009)... be able to reverse some of the damage to ... down their cigarettes, according to research out of the ... research is published in the December 15 issue of ... and Critical Care Medicine . , "We found that ... of the epithelium, or lining, of the airways in ...
(Date:12/6/2009)... Dec. 6 Pharmacyclics, Inc. (Nasdaq: ... Phase I/II study showing safety and clinical activity ... (NHL) treated with its HDAC inhibitor PCI-24781 as ... at the 51st ASH Annual Meeting being held ... ,, PCI-24781 is an oral pan-HDAC inhibitor which ...
(Date:12/6/2009)... a mainstay of multiple myeloma treatment may outperform ... patients who have received stem cell transplants from ... trial results to be presented by , ... of Hematology,s (ASH) annual meeting on Sunday, Dec. ... Room 243-245, 5:45 pm CT). , The ...
Breaking Medicine News(10 mins):Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2
... of Blacksburg, Va., a professor of virology in the ... Sciences and Pathobiology at Virginia Tech, has been awarded ... National Institutes of Health (NIH) to study the hepatitis ... is to develop a vaccine to protect people and ...
... trying to quit in the future could do ... according to research from The University of Nottingham. ... which exist naturally in our bodies (endocannabinoids), are ... treating conditions as diverse as obesity, diabetes, depression ...
... Herley Industries,Inc. (Nasdaq: HRLY ) expects to release ... March 12, 2008., A Conference Call has been ... 2008. Interested parties may join the conference by,dialing: (888) ... the conference call is scheduled to begin on March ...
... BERKELEY HEIGHTS, N.J., March 7 Genta,Incorporated (Nasdaq: ... entered into an,exclusive worldwide licensing agreement with Daiichi ... commercialization of tesetaxel,(formerly known as DJ-927). As a ... activity in its initial clinical trials, and,the drug ...
... will soon be possible for anyone over 60 to predict ... a simple web-based tool, developed by the Sydney-based Garvan Institute ... from the end of March at www.fractureriskcalculator.com , ... five factors including sex, age, weight, history of prior fracture, ...
... March 7 Novavax, Inc.,(Nasdaq: NVAX ) today ... full-year financial results in a press release to be ... 2008. The Company will hold an,investor conference call to ... Friday, March 14. The call will be hosted by ...
Other Medicine News:Health News:Human, animal vaccine development goal of hepatitis E virus research 2Health News:Human, animal vaccine development goal of hepatitis E virus research 3Health News:Curing addiction with cannabis medicines 2Health News:Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice 2Health News:Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel 2Health News:Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel 3Health News:Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel 4Health News:Launch of Web-based tool to predict risk of bone fracture 2Health News:Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call 2
...
BD Vacutainer® Specialty Tubes - Trace Element - Glass...
Inquire...
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
Medicine Products: